This inventor holds 7 USPTO granted patents, plus 1 CIPO patent. Top assignees: Pharmabcine Inc., E1 Biotech Co., Ltd., Korea Advanced Institute of Science and Technology. Active years: 2006-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seoul, KR (2006 - 2016)
- Chungcheongbuk-do, KR (2022)
Company Filing History:
4 out of 11 
1 out of 1 
1 out of 2,792 
Years Active: 2006-2026
Title: The Inventive Journey of Do-Yun Kim in Biomedical Innovations
Introduction: Do-Yun Kim, a prolific inventor based in Seoul, South Korea, has made significant contributions to the field of biomedical innovations. With a total of 6 patents to his name, Kim's groundbreaking work has focused on developing cutting-edge solutions for cancer treatment and angiogenesis inhibition.
Latest Patents:
1. Anti-PD-L1 antibody and use thereof: Do-Yun Kim's patent discloses an anti-PD-L1 antibody with applications in preventing or treating cancer. This innovation includes a pharmaceutical composition for cancer treatment, showcasing his dedication to improving medical therapies.
2. Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof: Kim's invention revolves around human monoclonal antibodies targeting vascular endothelial growth factor receptors. This breakthrough has promising implications for angiogenesis inhibition and cancer treatment efficacy.
Career Highlights: As an inventor, Kim has left his mark at companies like Pharmabcine Inc. and LG Cable Ltd., where he brought his visionary ideas to life. His inventive spirit and dedication to advancing medical technologies have been instrumental in shaping the landscape of biomedical research.
Collaborations: Throughout his career, Do-Yun Kim has worked alongside esteemed colleagues like Jin-San Yoo and Weon-Sup Lee. These collaborations have fostered creativity and innovation, leading to the development of novel solutions in the healthcare sector.
Conclusion: In conclusion, Do-Yun Kim's inventive journey exemplifies a relentless pursuit of excellence in biomedical innovations. His patents stand as a testament to his commitment to revolutionizing cancer treatment and angiogenesis inhibition, making a profound impact on the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile